Cutaneous vasculopathy and neutropenia associated with levamisole- adulterated cocaine

American Journal of the Medical Sciences

Volumn 345, Issue 1, 2013, Pages 45-51

  Arora, Natasha Purai ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Levamisole; Neutropenia; Retiform purpura; Vasculitis

Indexed keywords

ACETYLSALICYLIC ACID; COCAINE; CYCLOPHOSPHAMIDE; DALTEPARIN; LEVAMISOLE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENTOXIFYLLINE; PHENTOLAMINE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; WARFARIN;

ABOVE KNEE AMPUTATION; ANTICOAGULANT THERAPY; CLINICAL FEATURE; COCAINE DEPENDENCE; DEBRIDEMENT; DISEASE COURSE; HUMAN; LABORATORY TEST; LEUKOPENIA; NEUTROPENIA; PURPURIC RASH; RASH; RECURRENT DISEASE; REVIEW; SEX DIFFERENCE; SKIN BIOPSY; SKIN BLOOD VESSEL DISORDER; SKIN GRAFT; SMALL VESSEL VASCULITIS; THROMBOTIC VASCULOPATHY; TREATMENT OUTCOME; URINALYSIS;

EID: 84871948422     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31825b2b50     Document Type: Review

References (43)

1. Amery WK, Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmacol 1992;14:481-6.
2. Runge LA, Pinals RS, Lourie SH, et al. Treatment of rheumatoid arthritis with levamisole. A controlled trial. Arthritis Rheum 1977;20:1445-8.
3. Christensen KD. Treatment of seronegative spondylarthritis with levamisole: a double-blind placebo-controlled study. Int J Immunopharmacol 1979;1:147-50.
4. Tanphaichitr P, Tanphaichitr D, Sureeratanan J, et al. Treatment of nephrotic syndrome with levamisole. J Pediatr 1980;96:490-3.
5. Chang A, Osterloh J, Thomas J. Levamisole: a dangerous new adulterant. Clin Pharmacol Ther 2010;88:408-11.
6. Buchanan JA, Heard K, Burbach C, et al. Prevalence of levamisole in urine toxicology screens positive for cocaine in an inner-city hospital. JAMA 2011;305:1657-8.
7. Centers for Disease Control and Prevention (CDC). Agranulocytosis associated with cocaine use - four States, March 2008-November 2009. MMWR Morb Mortal Wkly Rep 2009;58:1381-5.
8. Macfarlane DG, Bacon PA. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J 1978;1:407-8.
9. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. National Survey on Drug Use and Health. 2008. doi:10.3886/ICPSR26701.v2.
10. Bradford M, Rosenberg B, Moreno J, et al. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010;152:758-9.
11. Buchanan JA, Vogel JA, Eberhardt AM. Levamisole induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 2011;7:83-4.
12. Walsh NMG, Green PJ, Burlingame RW, et al. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010;37:1212-9.
13. Waller JM, Feramisco JD, Alberta-Wszolek L, et al. Cocaineassociated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol 2010;63:530-5.
14. Farhat EK, Moorhead TT, Chaffing ML, et al. Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 2010;146: 1320-1.
15. Click J. Levamisole-induced retiform purpura. J Drug Dermatol 2011; 10:217.
16. Geller L, Whang TB, Mercer SE, et al. Retiform purpura: a new stigmata of illicit drug use? Dermatol Online J 2011;17:7.
17. Han C, Sreenivasan G, Dutz JP. Reversible retiform purpura: a sign of cocaine use. CMAJ 2011;183:E597-600.
18. Gross RL, Brucker J, Bahce-Altuntas A, et al. A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine. Clin Rheumatol 2011;30:1385-92.
19. Ching JA, Smith DJ Jr. Levamisole-induced necrosis of skin, soft tissue, and bone: case report and review of literature. J Burn Care Res 2012;33:e1-5.
20. Mouzakis J, Somboonwit C, Lakshmi S, et al. Levamisole induced necrosis of the skin and neutropenia following intranasal cocaine use: a newly recognized syndrome. J Drugs Dermatol 2011; 10:1204-7.
21. Jacob RS, Silva CY, Powers JG, et al. Levamisole-induced vasculopathy: a report of 2 cases and a novel histopathologic finding. Am J Dermatopathol 2012;34:208-13.
22. Lung D, Lynch K, Agrawal S, et al. Images in emergency medicine. Adult female with rash on lower extremities. Vasculopathic purpura and neutropenia caused by levamisole-contaminated cocaine. Ann Emerg Med 2011;57:307-11.
23. Zwang NA, Van Wagner LB, Rose S. A case of levamisole-induced systemic vasculitis and cocaine-induced midline destructive lesion: a case report. J Clin Rheumatol 2011;17:197-200.
24. Ullrich K, Koval R, Koval E, et al. Five consecutive cases of a cutaneous vasculopathy in users of levamisole-adulterated cocaine. J Clin Rheumatol 2011;17:193-6.
25. Chung C, Tumeh PC, Birnbaum R, et al. Characteristic purpura of the ears, vasculitis, and neutropenia - a potential public health epidemic associated with levamisole-adulterated cocaine. J Am Acad Dermatol 2011;65:722-5.
26. Jenkins J, Babu K, Hsu-Hung E, et al. ANCA-positive necrotizing vasculitis and thrombotic vasculopathy induced by levamisole-adulterated cocaine: a distinctive clinicopathologic presentation. J Am Acad Dermatol 2011;65:e14-16.
27. John S, Manda S, Hamrock D. Cocaine-induced thrombotic vasculopathy. Am J Med Sci 2011;342:524-6.
28. Scheinberg MA, Gomes Bezerra JB, Almeida FA, et al. Cutaneous necrotising vasculitis induced by levamisole. BMJ 1978;1:408.
29. Eddy EA, Symons JA. Nephrotic syndrome in childhood. Lancet 2003; 362:629-39.
30. Hobday TJ, Erlichman C. Adjuvant therapy of colon cancer: a review. Clin Colorectal Cancer 2004;1:230-36.
31. Parkinson DR, Cano PO, Jerry LM, et al. Complications of cancer immunotherapy with levamisole. Lancet 1977;1:1129-32.
32. Segal AW, Pugh SF, Levi AJ, et al. Levamisole-induced arthritis in Crohn's disease. Br Med J 1977;2:555.
33. Laux-End R, Inabenit D, Gerber HA, et al. Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 1996;75:355-6.
34. Zhu NY, LeGatt DF, Turner RA. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009;150:287-9.
35. United States Department of Health and Human Services. Substance Abuse and Mental Health Services Administration. Office of Applied Studies. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. http://oas. samhsa.gov/nsduh/2k9nsduh/2k9resultsp.pdf Accessed January 8, 2012.
36. Friedman DR, Wolfsthal SD. Cocaine-induced pseudovasculitis. Mayo Clin Pro 2005;80:671-3.
37. Wauwe JV, Janssen PAJ. On the biochemical mode of action of levamisole: an update. Int J Immunopharmacol 1991;13:3-9.
38. Chen LY, Lin YL, Chiang BL. Levamisole enhances immune response by affecting the activation and maturation of human monocyte- derived dendritic cells. Clin Exp Immunol 2008;151:174-81.
39. Menni S, Gianotti R, Ghio L, et al. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997;14:477-9.
40. Rongioletti F, Ghio L, Ginervi F, et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999;140:948-51.
41. Powell J, Grech H, Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 2002;27:32-3.
42. Khan TA, Cuchacovich R, Espinoza LR, et al. Vasculopathy, hematological, and immune abnormalities associated with levamisolecontaminated cocaine use. Semin Arthritis Rheum 2011;41:445-54.
43. Poon SH, Baliog CR Jr, Sams RN, et al. Syndrome of cocainelevamisole- induced cutaneous vasculitis and immune-mediated leukopenia. Semin Arthritis Rheum 2011;41:434-44.